UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2664-2672

2003

Volltextzugriff (PDF)

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors

Evidence-based complementary and alternative medicine, 2013-01, Vol.2013, p.964592-11

2013

Volltextzugriff (PDF)

Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance

Journal of clinical oncology, 1999-03, Vol.17 (3), p.791-795

1999

Volltextzugriff (PDF)

A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors

Clinical cancer research, 2005-06, Vol.11 (11), p.4144-4150

2005

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Weekly Oral Fluorouracil Given With Eniluracil and Low-Dose Leucovorin to Patients With Solid Tumors

Journal of clinical oncology, 2000-12, Vol.18 (23), p.3952-3963

2000

Volltextzugriff (PDF)

Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned

Current gastroenterology reports, 2006-08, Vol.8 (4), p.333-341

2006

Volltextzugriff (PDF)

Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”

Evidence-based complementary and alternative medicine, 2014, Vol.2014, p.1-2

2014

Volltextzugriff (PDF)

A Phase I Pharmacologic and Pharmacodynamic Study of Pyrazoloacridine Given as a Weekly 24-Hour Continuous Intravenous Infusion in Adult Cancer Patients

Clinical cancer research, 2002-07, Vol.8 (7), p.2149-2156

2002

Volltextzugriff (PDF)

Torsades de pointes occurring in association with terfenadine use

JAMA : the journal of the American Medical Association, 1990-12, Vol.264 (21), p.2788

1990

Volltextzugriff (PDF)

Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells

Biochemical pharmacology, 1999-08, Vol.58 (3), p.477-486

1999

Volltextzugriff (PDF)

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Journal of clinical oncology, 2000-02, Vol.18 (3), p.659-667

2000

Volltextzugriff (PDF)

Mistletoe and Gemcitabine in Patients with Advanced Cancer: A Model for the Phase I Study of Botanicals and Botanical-Drug Interactions in Cancer Therapy

Integrative cancer therapies, 2003-12, Vol.2 (4), p.345-352

2003

Volltextzugriff (PDF)

Clinical Picture: Extraocular muscle palsy from metastatic prostate cancer

The lancet oncology, 2003-06, Vol.4 (6), p.358

2003

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule

Cancer chemotherapy and pharmacology, 2003-07, Vol.52 (1), p.79-85

2003

Volltextzugriff (PDF)

A phase i and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin

Cancer chemotherapy and pharmacology, 2003-12, Vol.52 (6), p.487-496

2003

Volltextzugriff (PDF)

A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients

Cancer chemotherapy and pharmacology, 2001-09, Vol.48 (3), p.215-222

2001

Volltextzugriff (PDF)

Clinical significance of the FV:Q506 mutation in unselected oncology patients

The American journal of medicine, 1996-10, Vol.101 (4), p.406-412

1996

Volltextzugriff (PDF)

Extraocular muscle palsy from metastatic prostate cancer

The lancet oncology, 2003-06, Vol.4 (6), p.358-358

2003

Volltextzugriff (PDF)

A phase I pharmacologic and pharmacogenetictrial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors

Clinical cancer research, 2005, Vol.11 (11), p.4144-4150

2005

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

Cancer chemotherapy and pharmacology, 2001, Vol.47 (2), p.117-125

2001

Volltextzugriff (PDF)

Gaucher's disease initially diagnosed as depression

The American journal of psychiatry, 1997-02, Vol.154 (2), p.290a-290

1997

Volltextzugriff (PDF)

Torsades de pointes occurring in association with terfenadine use

JAMA : the journal of the American Medical Association, 1991-11, Vol.266 (17), p.2375

1991

Volltextzugriff (PDF)

Clinical significance of the FV:Q 506 mutation in unselected oncology patients

The American journal of medicine, 1996, Vol.101 (4), p.406-412

1996

Volltextzugriff (PDF)

Ultrastable silver nanoparticles

Nature (London), 2013-09, Vol.501 (7467), p.399-402

2013

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)
Reviews
(2)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(28)
Life Sciences & Biomedicine
(26)
Male
(18)
Female
(17)
Aged
(15)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(15)
Adult
(13)
Oncology
(13)
Antineoplastic Agents
(12)
Pharmacology. Drug Treatments
(12)
Chemotherapy
(10)
Neoplasms - Drug Therapy
(9)
Infusions, Intravenous
(8)
Drug Administration Schedule
(7)
Pharmacology & Pharmacy
(6)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dose-Escalating and Pharmacological Study of Oxaliplatin in Adult Cancer Patients With Impaired Renal Function: A National Cancer Institute Organ Dysfunction Working Group Study

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors

Rituximab Therapy in Hematologic Malignancy Patients With Circulating Blood Tumor Cells: Association With Increased Infusion-Related Side Effects and Rapid Blood Tumor Clearance

A Phase I Pharmacologic and Pharmacogenetic Trial of Sequential 24-Hour Infusion of Irinotecan Followed by Leucovorin and a 48-Hour Infusion of Fluorouracil in Adult Patients with Solid Tumors

Phase I and Pharmacokinetic Trial of Weekly Oral Fluorouracil Given With Eniluracil and Low-Dose Leucovorin to Patients With Solid Tumors

Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned

Erratum to “NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors”

A Phase I Pharmacologic and Pharmacodynamic Study of Pyrazoloacridine Given as a Weekly 24-Hour Continuous Intravenous Infusion in Adult Cancer Patients

Torsades de pointes occurring in association with terfenadine use

Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells

Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients

Mistletoe and Gemcitabine in Patients with Advanced Cancer: A Model for the Phase I Study of Botanicals and Botanical-Drug Interactions in Cancer Therapy

Clinical Picture: Extraocular muscle palsy from metastatic prostate cancer

Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule

A phase i and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin

A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients

Clinical significance of the FV:Q506 mutation in unselected oncology patients

Extraocular muscle palsy from metastatic prostate cancer

A phase I pharmacologic and pharmacogenetictrial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors

Pharmacokinetics and pharmacodynamic effects of 5-fluorouracil given as a one-hour intravenous infusion

Gaucher's disease initially diagnosed as depression

Torsades de pointes occurring in association with terfenadine use

Clinical significance of the FV:Q 506 mutation in unselected oncology patients

British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines

Ultrastable silver nanoparticles

Suchergebnisse filtern